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Leukocyte Infiltration, Neuronal Degeneration, and
Neurite Outgrowth after Ablation of Scar-Forming,
Reactive Astrocytes in Adult Transgenic Mice
provision of metabolic substrates for neurons, and inter-
actions with endothelia to create and maintain the
blood±brain barrier (BBB) (Kettenmann and Ransom,
1995). The degree to which these functions are sus-
tained, augmented, or lost by astrocytes that become
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of the gene for glial fibrillary acidic protein (GFAP), anUniversity of California, San Francisco
San Francisco, California 94141 intermediate filament protein whose expression in the
CNS is restricted to astrocytes and related cells. Al-
though many astrocytes in the mature, uninjured CNS
do not express levels of GFAP detectable with standardSummary
immunohistochemical procedures, GFAP expression is
upregulated to a readily detectable level in most, if notReactive astrocytes adjacent to a forebrain stab injury
all, reactive astrocytes after CNS injury (Eddleston andwere selectively ablated in adult mice expressing HSV-
Mucke, 1993; Ridet et al., 1997). To achieve cellularTK from the Gfap promoter by treatment with gan-
ablation, we used the thymidine kinase gene of herpesciclovir. Injured tissue that was depleted of GFAP-
simplex virus (HSV-Tk). Proliferating cells that expresspositive astrocytes exhibited (1) a prolonged 25-fold
transgene-derived HSV-TK metabolize the antiviral agentincrease in infiltration of CD45-positive leukocytes,
ganciclovir (GCV) to toxic nucleotide analogs that dis-including ultrastructurally identified monocytes, mac-
turb nucleic acid synthesis and induce cell death (Chengrophages, neutrophils, and lymphocytes, (2) failure
et al., 1983; Borrelli et al., 1989; Heyman et al., 1989).of blood±brain barrier (BBB) repair, (3) substantial
In this manner, cell ablation can be regulated by whereneuronal degeneration that could be attenuated by
and when GCV is administered. We have described pre-chronic glutamate receptor blockade, and (4) a pro-
viously the generation of transgenic mice expressingnounced increase in local neurite outgrowth. These
HSV-Tk from the mouse Gfap promoter and shown thatfindings show that genetic targeting can be used to
reactive, transgene-expressing astrocytes adjacent toablate scar-forming astrocytes and demonstrate roles
a forebrain stab injury are ablated by GCV (Bush et al.,for astrocytes in regulating leukocyte trafficking, re-
1998). Here, we report the effects of ablation of reactivepairing the BBB, protecting neurons, and restricting
astrocytes after forebrain stab injury through cerebralnerve fiber growth after injury in the adult central ner-
cortex, hippocampus, and thalamus in adult mice. Wevous system.
find that astrocytes play fundamental roles in regulating
leukocyte infiltration, repairing the blood±brain barrier
(BBB), protecting neurons, and restricting nerve fiberIntroduction
growth after CNS injury.
Injury, infection, and degenerative disease in the central
nervous systems (CNS) are invariably accompanied by Results
the hypertrophy, altered gene expression, and prolifera-
tion of astrocytes, a process commonly referred to as Regulation of HSV-TK and GFAP in Astrocytes
reactive astrocytosis. While much is known about mole- after Stab Injury
cules that either influence, or are produced by, reactive Transgene-derived HSV-TK expressed in brains of mice
astrocytes (Eddleston and Mucke, 1993; Ridet et al., used in this study migrates similarly to native HSV-TK
1997), the functions of these cells are incompletely un- in Western blot and is localized specifically to astrocytes
derstood. Considerable evidence suggests that in unin- by immunohistochemistry (Bush et al., 1998). To com-
jured CNS tissue, nonreactive astrocytes are normally pare the regulation of transgene-derived HSV-TK with
involved in maintenance of the extracellular ionic en- that of endogenous GFAP at the single cell level, we
vironment and pH, uptake of extracellular glutamate, quantitatively analyzed sections immunohistochemi-
cally double-stained for both proteins. In hippocampus,
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expression in uninjured mice, 85% of GFAP-positivecam.ac.uk).
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HSV-TK-positive cells increased, and the proportion of
double-labeled cells rose to 92% (Figures 1A, 1B, and
1D). In thalamus, few cells immunoreactive for either
protein could be detected in uninjured mice, whereas
after injury, intensely stained GFAP- and HSV-TK-posi-
tive cells formed a densely packed scar in which the
proportion of double-labeled cells was over 98%. Quali-
tative analysis of cerebral neocortex yielded similar ob-
servations. In all regions, some GFAP-positive cells
failed to show detectable levels of HSV-TK, but this
percentage was small after injury. More importantly,
HSV-TK was always colocalized with GFAP, and no cells
were observed in any brain region that were positive for
HSV-TK but not GFAP (Figures 1A, 1C, and 1D). These
findings indicate that transgene-derived HSV-TK is reg-
ulated similarly to endogenous GFAP and that nearly all
reactive astrocytes, but not other cell types, express
HSV-TK after CNS injury.
Effects of 7 Days of Subcutaneous GCV on
Reactive Astrocytes after Stab Injury
We found previously that exposure to GCV for several
days was needed to achieve substantial death of
astrocytes expressing HSV-TK in vitro and that both 7
and 14 days of continuous subcutaneous (s.c.) GCV
delivery were effective in ablating astrocytes immedi-
ately adjacent to forebrain stab injury (Bush et al., 1998).
However, 14 days of GCV was invariably lethal to
transgenic mice due to ablation of GFAP-expressing
enteric glia and consequent inflammation and necrosis
of the small intestine. Because 7 days of s.c. GCV was
well tolerated by all mice and caused no obvious patho-
logical changes in the bowel (Bush et al., 1998), this
delivery regimen was used in the present study.
The efficiency and longevity of ablation of transgene-
expressing reactive astrocytes after 7 days of s.c. GCV
treatment was examined by immunohistochemical de-
tection of GFAP and HSV-TK at 7, 14, 21, and 35 days
after stab injury. Findings were indistinguishable in three
groups of control mice consisting of transgenic and non-
transgenic mice not given GCV, and nontransgenic mice
(E±L) or 35 (M and N) day survival. Single staining for GFAP (E, G,
M, and N), HSV-TK (F and H), or BRDU (I and K). Double staining
for BRDU (brown) and GFAP (blue) (J and L). Black and red arrow-
heads demarcate the zone of proliferating, scar-forming reactive
astrocytes normally adjacent to stab injury, from which astrocytes
have been ablated in GCV-treated transgenic mice. Scale bars: (E,
G, I, K, and M), 50 mm; (F, H, J, L, and N), 20 mm.
Figure 1. Cellular Expression Profile of the GFAP-HSV-TK Transgene (E) Nontransgenic (NT). GCV had no effect on astrocyte scar for-
and Selective Ablation by GCV of Proliferating, Transgene-Express- mation.
ing Reactive Astrocytes (F) Transgenic (Tg) not given GCV. Reactive astrocytes express
(A) Mean cell number 6 SEM (n 5 4 per group) of double- or single- HSV-TK.
labeled astrocytes after two-color immunohistochemistry. (G and H) Transgenic. GCV has depleted astrocytes from wound
(B) Percentage of double-labeled astrocytes as compared with the margins. Neighboring astrocytes have upregulated GFAP or
total number of GFAP-positive astrocytes after two-color immuno- HSV-TK.
histochemistry. (I and J) Nontransgenic. Many BRDU- and GFAP-positive, proliferat-
(C and D) Two-color immunohistochemistry of hippocampal ing astrocytes are present immediately adjacent to wound margins.
astrocytes in transgenic mice, untreated (C), or after stab injury (D) (K and L) Transgenic. GCV has depleted BRDU-labeled, proliferating
shows that brown-stained (HSV-TK) cell bodies and blue-stained astrocytes from wound margins. A few GFAP-negative and BRDU-
(GFAP) processes belong to the same cells. Scale bars, 5 mm. positive presumptive leukocytes remain.
(E±N) One- or two-color immunohistochemistry of reactive astrocytes (M and N) Transgenic given GCV. GFAP-positive astrocytes remain
adjacent to stab injury (black arrowheads) in thalamus after 14 depleted from wound margins after 35 days.
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given GCV s.c. after injury. In these mice at 7 or 14 days
after injury, there was a marked increase in the number
and size of immunoreactive astrocytes along wound
margins, with formation of a compact glial scar (Figures
1E and 1F). The appearance was similar at 21 days,
whereas reactive astrocytosis had begun to subside by
35 days. In contrast, in GCV-treated transgenic mice at
7 or 14 days after injury, there was a pronounced reduc-
tion in the number of GFAP and HSV-TK immunoreactive
astrocytes immediately adjacent to the wound that
was particularly striking in thalamus, where immediate
wound margins were essentially devoid of immunoreac-
tive astrocytes for several hundred micrometers away
from the center of the wound (Figures 1G and 1H). The
pattern of immunohistochemical staining suggested
that the death of astrocytes immediately next to the
wound triggered astrocytosis in the outwardly adjacent
cells after GCV delivery had stopped (Figures 1G and
1H). In addition, astrocytes were regularly ablated for
much greater distances of up to several millimeters away
from the stab wound in hippocampus, creating a zone
essentially devoid of immunoreactive astrocytes along
much of the CA1 pyramidal layer (Figures 2C and 2D).
The appearance did not differ substantially at 21 days,
and even at 35 days, tissue ablated of GFAP- or HSV-
TK-positive cells persisted along wound margins or in
CA1, in spite of varying degrees of tissue collapse (Fig-
ures 1M, 1N, and 2E), indicating that ablated astrocytes
were not replaced by migrating adjacent astrocytes or
precursor cells.
The effect of GCV treatment on proliferating astrocytes
was examined in mice injected with BRDU on day 3
after injury, the time of peak astrocyte cell division (Amat
Figure 2. Proliferation, and Ablation by GCV, of Transgene-Express-et al., 1996). At 14 days after injury, nontransgenic ani-
ing Reactive Astrocytes in Hippocampal CA1mals with or without s.c. GCV treatment exhibited many
(A±G) One- or two-color immunohistochemistry of reactiveBRDU-labeled cells in a narrow zone extending several
astrocytes adjacent to stab injury (arrowheads) in hippocampus
hundred micrometers adjacent to the stab wound; most after 14 (A±D, F, and G) or 35 (E) day survival. Single staining for
of these cells were identified as GFAP-positive astrocytes BRDU (A and B) or HSV-TK (C±E). Double staining for BRDU (brown)
by double-labeling immunohistochemistry (Figures 1I and GFAP (blue) (F and G). Scale bars: (A and B), 75 mm; (C±E), 50
mm; (F and G), 20 mm.and 1J). Many BRDU-labeled astrocytes were also pres-
(A and F) Nontransgenic. Many BRDU- and GFAP-positive, prolifer-ent along the hippocampal CA1 pyramidal layer for up
ating astrocytes are present not only immediately adjacent to woundto several millimeters away from the wound (Figures 2A
margins, but also extending for long distances along CA1 pyramidal
and 2F). GCV-treatment of transgenic mice ablated most layer ([P], arrows).
BRDU-positive cells, and essentially all BRDU-labeled (B and G) Transgenic. GCV has depleted BRDU-labeled, proliferating
GFAP-positive astrocytes, including those in CA1 (Fig- astrocytes from the wound margins as well as from the CA1 pyrami-
dal layer ([P], arrows). Nondividing, BRDU-negative, GFAP-positiveures 1K, 1L, 2B, and 2G). Only a small number of BRDU-
astrocytes remain.positive and GFAP-negative cells likely to be proliferating
(C) Transgenic not given GCV. Reactive astrocytes express highinflammatory cells remained. These findings demonstrate
levels of HSV-TK in injured hippocampus.
the presence of dividing GFAP-positive astrocytes in all (D and E) Transgenic. GCV has depleted proliferating astrocytes
regions where astrocyte ablation occurred and show from the CA1 pyramidal layer at 14 days (D), and these have not
been replaced at 35 days (E) resulting in tissue collapse. Manythat GCV treatment in transgenic mice killed most, if not
nondividing astrocytes adjacent to the pyramidal layer were notall, dividing astrocytes.
ablated by GCV.
Effects of Astrocyte Ablation on Tissue Integrity geal cells (Figures 3A, 3B, and 4A). Within the 400 mm of
and Inflammatory Cells neural parenchyma immediately adjacent to the wound
The appearance of tissue after stab injury was indis- margin that contained scar-forming, reactive GFAP-
tinguishable in the three groups of control mice: trans- positive astrocytes: (1) there was no evidence of intersti-
genic and nontransgenic mice not given GCV and non- tial edema or substantial neuronal loss in semi- or ultra-
transgenic mice given GCV. The center of the stab thin sections; (2) activated microglia, identified as finely
wound was regularly defined by a narrow column of branched cells positive for tomato±lectin binding and
inflammatory cells (no more than several cells wide) and light CD45 staining, were present at 7 and 14 days but
had resolved in most cases by 21 or 35 days; (3) intenselydelimited by a thin layer of fibronectin-positive menin-
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Figure 3. Integrity of Injured Tissue and Leukocyte Morphology
(A±F) Toluidine blue-stained semithin sections of neural parenchyma adjacent to stab injury (arrowheads) in thalamus after 7 day survival.
Black and red arrowheads demarcate the zone that either contains proliferating, scar-forming reactive astrocytes in control mice, or from
which astrocytes have been ablated in GCV-treated transgenic mice. Scale bars: (A and D), 50 mm; (B and E), 10 mm; (C and F), 4 mm.
(A±C) Nontransgenic control.
(D±F) Transgenic given GCV. Astrocyte ablation is accompanied by interstitial edema (asterisk), infiltration of polymorphic leukocytes, and
denuding of capillary (c) walls (arrows). PMN, polymorphonuclear neutrophil.
(G±J) Transgenic given GCV. Electron microscopy of leukocytes in neural parenchyma after astrocyte ablation shows morphologies typical
of monocytes (G), macrophages (H), polymorphonuclear neutrophils (I) with lobulated nuclei (n1±n4), and lymphocytes (J). Scale bars: (G±J), 1 mm.
stained, globoid, and unbranched CD45-positive cells lymphocytes, and occasional mast cells were present
(Figures 3G±3J and 5L). Immediately adjacent to thiswith the appearance of leukocytes were scattered at low
density; and (4) at the ultrastructural level, extravasted zone, there were numerous activated, finely branched
microglia at 7 or 14 days (Figure 4F). Globoid, unbranch-leukocytes exhibited morphologies typical of mono-
cytes (Figures 3A±3C and 4C±4E). CD45-positive leuko- ing CD45-positive leukocytes were regularly scattered
throughout neural parenchyma up to 2 mm or more awaycytes were rare in neural parenchyma at distances
greater than 1 mm from the wound margins. from the wound margin. By 21 and 35 days, interstitial
edema and microglial activation had resolved and vary-The findings were markedly different in transgenic
mice given GCV. In these animals, the center of the ing degrees of tissue collapse had occurred along
wound margins and in hippocampal CA1, but manystab wound was also defined by a narrow column of
inflammatory cells and delimited by a thin layer of fibro- CD45-positive leukocytes continued to be present in
tissue depleted of immunoreactive astrocytes bothnectin-positive meningeal cells (Figures 3D, 3E, and 4B).
However, within the 400 mm of neural parenchyma im- along and away from the wound margin as in CA1 (Fig-
ures 1M, 1N, 2E, and 4H±4J). The pharmacological atten-mediately adjacent to the wound margin, from which
astrocytes had been depleted: (1) at 7 days after stab uation of neuronal degeneration in GCV-treated trans-
genic mice (see below) did not prevent the infiltrationinjury, there was pronounced interstitial edema, numer-
ous blood±borne inflammatory and phagocytic cells, of CD45-positive leukocytes into CNS parenchyma at
14 days.and substantial neuronal degeneration (Figures 3D±3J);
(2) blood vessels were markedly dilated and endothelial
cells were denuded of cellular contacts at many sites
Effects of Astrocyte Ablation and Replacement(Figures 3F and 5K±5M); (3) compared with controls,
on BBB Repairthere was a statistically significant (p , 0.001) 25-fold
After penetrating injury to the CNS, the BBB is damagedgreater density of globoid, unbranching CD45-positive
and becomes leaky to endogenous and exogenousleukocytes at 14 days that persisted at 35 days (Figures
blood±borne macromolecules. In rodents, this leakiness4C±4L); and (4) at the ultrastructural level, extravasated
is repaired within 10 to 14 days. Because astrocytesleukocytes were common, most of which exhibited
have been implicated in establishing and maintainingmorphologies typical of monocytes and activated mac-
rophages, but many polymorphonuclear neutrophils, the BBB, we investigated the effects on BBB repair of
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(1) astrocyte ablation that caused substantial denuding
of astrocyte endfeet from blood vessels (Figures 3E, 3F,
5K, and 5L) and (2) astrocyte replacement to such lesions
using dispersed cell grafts prepared from astrocyte-
enriched tissue cultures of brain tissue from neonatal,
nontransgenic mice of line 7.1. To evaluate BBB func-
tion, we looked at entry into CNS parenchyma of serum
immunoglobulin (IgG) and intravenously injected horse-
radish peroxidase (HRP), as examples of endogenous
and exogenous macromolecules normally excluded
from brain parenchyma except at sites that do not ex-
hibit a BBB (Broadwell and Brightman, 1976; Broadwell
and Sofroniew, 1993). In uninjured transgenic mice, GCV
did not cause detectable disruption of the BBB. At 7
days after stab injury, there was pronounced entry of
IgG and HRP into forebrain parenchyma adjacent to the
wound in all mice regardless of treatment group (Figure
5A). By 14 days after injury, there was no entry of IgG
or HRP at the wound site in control mice, indicating that
the BBB had resealed (Figures 5B, 5D, 5G, and 5H). In
contrast, after injury in GCV-treated transgenic animals
entry of IgG or HRP into parenchyma adjacent to wound
margins persisted at all levels along the stab injury at
14, 21, and 35 days (Figures 5C, 5E, 5F, 5I, and 5J).
Dispersed cell grafts of astrocytes implanted into the
wound area of GCV-treated transgenic mice at 7 or 14
days after injury prevented entry of IgG or HRP into
adjacent wound margins in those areas where the grafts
were appropriately located and had survived and ap-
peared healthy at 28 or 35 days, indicating that the BBB
had resealed (Figures 5N±5R).
Effects of Astrocyte Ablation on Local Neurons
In all three groups of control mice, at all survival times,
tissue adjacent to the stab injury in cortex, hippocam-
pus, and thalamus exhibited many healthy neurons sur-
rounded by reactive astrocyte processes, and there was
no appreciable loss of neurons (Figures 3A±3C, 6A, 6E,
and 6H). In contrast, in GCV-treated transgenic mice,
loss of neurons occurred in all brain tissue depleted of
astrocytes (Figures 3D±3F, 6B, 6F, 6I, and 6J). Quantita-
tive measurements were performed in hippocampal
CA1, where the viability of densely packed pyramidal
neurons is easily assessed. In control mice, tissue not
containing pyramidal neurons extended for a mean dis-
tance of less than 100 mm from the center of the wound
(Figure 6D). In GCV-treated transgenic mice, a pro-
nounced loss of pyramidal neurons extended for a mean
distance of nearly 1500 mm (Figure 6D). Areas exhibiting
Figure 4. Immunoreactive Meningeal Cells and Leukocytes
(A and B) Immunohistochemistry of fibronectin at the site of stab
injury (arrowheads) in the thalamus at 14 days. Staining is not obvi-
ously different in nontransgenic (A) and GCV-treated transgenic of leukocytes (arrows) have entered the neural parenchyma, and
mice (B). Scale bars, 20 mm. there is little evidence of microglial activation.
(C) Mean cell number 6 SEM (n 5 5 per group) of CD45 immunoreac- (F and I) Transgenic given GCV. In the zone of astrocyte ablation,
tive cells immediately adjacent to wound margins under different intensely stained, CD45-positive cells with rounded cell bodies typi-
experimental conditions. cal of leukocytes are densely packed at 14 (F and G) and persist at
(D±L) Immunohistochemistry of CD45 adjacent to stab injury (black 35 (H and I) days. Asterisk in (F) and (H) labels tissue adjacent to
arrowhead) in thalamus. Black and red arrowheads demarcate the the zone of astrocyte ablation, which at 14 days contains many (F),
zone that either contains proliferating, scar-forming reactive and at 35 days few (H), activated microglia with fine, CD45-positive
astrocytes in control mice, or from which astrocytes have been processes.
ablated in GCV-treated transgenic mice. Scale bars: (D, F, and H), (J) Transgenic given GCV. In hippocampal CA1, many CD45 positive
50 mm; (E, G, I, and J), 20 mm; (K and L), 2.5 mm. leukocytes persist at 35 days in areas from which astrocytes have
(D and E) Nontransgenic control. At 14 days after stab injury, few been ablated.
intensely stained CD45-positive cells with round cell bodies typical (K and L) Details respectively of (G) and (J).
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loss of pyramidal neurons corresponded precisely to
areas depleted of dividing astrocytes (Figures 2, 6B, and
6F). At the shorter survival time of 7 days, simultane-
ous visualization of CA1 neurons and GFAP-positive
astrocytes revealed that areas depleted of astrocytes
furthest away from the stab wound contained many via-
ble CA1 neurons, suggesting that loss of astrocytes
preceded loss of neurons (Figure 6K). By 21 or 35 days,
there were few surviving neurons, and considerable tis-
sue collapse had occurred (Figure 6B). At 7 days, many
CA1 neurons exhibited morphological criteria com-
patible with excitotoxic cell death, including nuclear
condensation with chromatin clumping, vacuolization,
membrane disintegration, and dissolution of the cyto-
plasm (Figures 6I, 6J, and 6L). Because hippocampal
neurons are exquisitely sensitive to excitotoxicity, and
genetic disruption of glutamate uptake by astrocytes
can cause seizures and excitotoxic cell death (Rothstein
et al., 1996), we tested the effects of memantine, an
antagonist of the N-methyl-D-aspartate (NMDA) gluta-
mate receptor shown previously to attenuate endoge-
nous glutamate-mediated excitotoxicity in transgenic
mice (Toggas et al., 1996). In GCV-treated transgenic
mice given continuous s.c. memantine, loss of pyramidal
neurons extended about 400 mm, representing a signifi-
cant decrease compared with GCV-treated transgenic
mice not given memantine, and a significant increase
compared with controls (p , 0.01; Figures 6C and 6D).
Effects of Astrocyte Ablation on Local Nerve Fibers
In control mice, tissue that contained scar-forming reac-
tive astrocyte processes in the immediately vicinity of
the stab injury exhibited few nerve fibers as revealed
with both silver staining and immunohistochemistry for
neurofilament M (Figures 7A, 7B, 7E, and 7F). In contrast,
in GCV-treated transgenic mice, tissue depleted of
astrocytes along the stab injury regularly contained a
dense network of randomly oriented fibers (Figures 7C,
7D, 7G and 7H). These fibers were confined to the imme-
diate wound margins depleted of astrocytes and did not
extend into adjoining regions that contained surviving
reactive astrocytes in neighboring sections. Many fibers
continue to enter neural parenchyma at 14 (C, I, and J), 21 (E), and
35 (F) days.
(K±M) Transgenic given GCV. Electron microscopy of tissue near
stab injury similar to that in Figure 3F. Capillary (c) endothelial cells
(e) are denuded (arrows) of astrocyte endfeet but retain contacts
with pericytes (Per) and are surrounded by macrophages, neutro-
phils (PMN), disorganized neuropil, and cellular debris. RBC, red
blood cells. Scale bars: (K), 2 mm; (L), 2.5 mm; (M), 0.8 mm.
(N±R) Transgenics given GCV followed by grafts of nontransgenic
Figure 5. Blood±Brain Barrier cultured astrocytes at 7 (N and P±R) or 14 (O) days. HRP (N and O)
(A±F) Immunohistochemistry of IgG (A±C and F), histochemistry of and IgG (R) fail to enter neural parenchyma at 28 (N and P±R) or 35
HRP alone (D and E), and counter-stained with cresyl violet (G±J) (O) days. Scale bars: (N), 1200 mm; (O), 50 mm; (P±R), 200 mm.
after stab injury (arrowheads). Scale bars: (A±F), 1200 mm; (G and (P±R) Neighboring sections of the same area showing in (P) that TK-
I), 120 mm; (H and J), 50 mm. positive, transgene-expressing astrocytes are ablated at the stab
(A, B, D, G, and H) Nontransgenic. After injury, IgG and HRP enter injury, in (Q) that grafted GFAP-positive, nontransgenic (TK-negative
neural parenchyma at 7 (A), but are excluded at 14 (B, G, and H) in [P]) astrocytes are resident along the injury, and in (R) that IgG
and 21 (D) days, except at sites with a normally leaky BBB such as does not enter neural parenchyma along the grafted site. Black and
median eminence (me). red arrowheads demarcate, respectively, the stab injury and zone
(C, E, F, I, and J) Transgenic given GCV. After injury, IgG and HRP from which astrocytes have been ablated. bv, blood vessel; g, graft.
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Figure 6. Effects of Astrocyte Ablation on Hippocampal CA1 Pyramidal Neurons
(A±C) Cresyl violet staining of hippocampus after stab injury (arrowheads) under three experimental conditions. In a nontransgenic mouse (A),
pyramidal neurons appear healthy. In a GCV-treated transgenic mouse (B), pyramidal neurons have degenerated along the entire length of
CA1 (arrows). In a GCV-treated transgenic mouse also given memantine (MMT) (C), pyramidal neurons have degenerated only immediately
adjacent to the wound (arrows). Scale bars, 150 mm.
(D) Mean distance 6 SEM (n 5 8 per group, age-matched females) of the extent of degenerating pyramidal neurons along CA1 under the
three experimental conditions shown in (A)±(C).
(E±G) Confocal microscopy of immunofluorescence for GFAP (green) combined with propidium iodide as a nuclear counter-stain (red) shown
individually (E1 and E2 through G1 and G2) and overlaid (E3, F3, and G3) in the CA1 pyramidal layer near stab injury under the same three
experimental conditions in (A)±(C). In a nontransgenic mouse (E1±E3), many GFAP-positive astrocytes extend processes among pyramidal
neurons that appear healthy. In a GCV-treated transgenic mouse (F1±F3), astrocytes are ablated and pyramidal neurons have degenerated
mice. In a GCV-treated transgenic mouse also given MMT (G1±G3), astrocytes are ablated but pyramidal neurons remain viable. Scale bars,
10 mm.
(H±J) Toluidine blue-stained semithin sections of CA1 at 7 days after stab injury. Healthy pyramidal neurons are present immediately adjacent
to the wound margin (arrowhead) in a nontransgenic mouse (H), whereas in a GCV-treated transgenic mouse (I and J) pyramidal neurons are
degenerating for a considerable distance away from the wound. Scale bars: (H and I), 20 mm; (J), 10 mm.
(K) Confocal microscopy of immunofluorescence for GFAP (green) with propidium iodide (red) in CA1 7 days stab injury (arrowhead) in a GCV-
treated transgenic mouse. At this time point, astrocyte ablation extends further along CA1 than does the degeneration of pyramidal neurons
(arrow). Scale bar, 80 mm.
(L) Transgenic given GCV. Electron microscopic image of a degenerating pyramidal neuron from the area shown in (J). Scale bar, 1.5 mm.
were finely branched and had a sprouting appearance, Discussion
and many fibers circled back on each other to run up
or down along the wound margin within the area de- In this study, we demonstrate the efficacy of a genetic
targeting strategy for ablation of scar-forming reactivepleted of astrocytes.
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in adult transgenic mice did not detectably ablate HSV-
TK-expressing, GFAP-positive astroglial cells in major
organs, including the uninjured CNS (Bush et al., 1998).
GCV does not cross the BBB well (Brewster et al., 1994)
but will enter CNS parenchyma at sites of injury where
the BBB is compromised. In addition to exposure to
GCV, ablation of reactive astrocytes in our mice ap-
peared to require both expression of HSV-TK and induc-
tion of cell division after injury, in agreement with studies
indicating that after phosphorylation by transgene-
derived HSV-TK, GCV-mediated cell death results from
formation of toxic intermediates that disrupt DNA repli-
cation and preferentially kill dividing cells (Frank et al.,
1984; Borrelli et al., 1989). It deserves mention that some
nondividing HSV-TK-expressing cells may be killed by
an as yet unknown mechanism (Wallace et al., 1991)
and that dying astrocytes may be able to injure or kill
neighboring astrocytes through specific gap junctions
(Budd and Lipton, 1998; Lin et al., 1998). Whether these
mechanisms occurred in our mice is not certain but
would not have altered the interpretation of our results,
which are based on the histologically demonstrated ab-
lation of HSV-TK- and GFAP-positive astrocytes.
Both the specificity and efficacy of our model compare
favorably with those of other reported procedures for
killing or inactivating astrocytes, such as irradiation, an-
timitotic agents, and various toxins (Holash et al., 1993;
Krum, 1996; Largo et al., 1996). While useful in certain
contexts, these procedures are limited by their uncertain
specificity for all types of glia or dividing cells in general.
Transgenic mice expressing HSV-TK under regulation
of a fragment of the human GFAP promoter have been
generated by others, who report that single bolus i.p.
injections of GCV in the neonatal period disrupt the cyto-
architecture of the developing cerebellum, whereas sin-
gle GCV injections had no obvious effect on the unin-
jured adult CNS (Delaney et al., 1996).
Several lines of evidence support the specificity of
astrocyte ablation in our model. Under various ex-
Figure 7. Neurite Outgrowth at Wound Margins perimental conditions, nontransgenic mice given GCV
(A±H) Silver staining (A±D) and immunohistochemistry of neurofila- were indistinguishable from those not given GCV. In
ment M at the site of stab injury (arrowheads) in the thalamus after astrocyte-enriched primary cultures of neonatal brains,
35 days. Scale bars: (A, C, E, and G), 20 mm; (B, D, F, and H), 10 mm. GCV killed transgene-expressing astrocytes, but neigh-
(A, B, E, and F) Nontransgenic. Few fibers are present in the vicinity
boring GFAP- and HSV-TK negative fibroblasts andof the wound.
meningeal cells survived and increased in number(C and D) GCV-treated transgenic. Many fibers extend along the
(Bush et al., 1998). Double-staining immunohistochemi-wound margins.
cal analysis demonstrated at the single cell level that
expression of HSV-TK was always restricted to GFAP-
positive astrocytes. All transgenic and nontransgenicastrocytes after CNS injury. Applying this strategy, we
mice used for comparisons were derived from the same
found that loss or dysfunction of reactive astrocytes
inbred colony and had similar genetic backgrounds,
leads to a prolonged increase in leukocyte infiltration,
making it unlikely that experimentally induced differ-
failure of BBB repair with vasogenic edema, neuronal ences were spurious effects related to genetic back-
degeneration, and increased outgrowth of nerve fibers ground (Choi, 1997). Together, these findings indicate
in injured CNS parenchyma. that GCV had no detectable effects on non-transgene-
expressing cells, that GCV preferentially killed dividing
Subcutaneous GCV Treatment Selectively Ablates transgene-expressing astrocytes, and that lethal metab-
Transgene-Expressing Reactive Astrocytes olites of GCV were not released in sufficient quantities
after Forebrain Stab Injury by HSV-TK-expressing cells to kill neighboring, non-
Our findings show that transgenically targeted HSV-TK transgene-expressing cells. Thus, our model is both ef-
combined with 7 days of s.c. GCV allows the selective, fective and selective for ablation of scar-forming, reac-
site-specific, and temporally regulatable ablation of tive astrocytes in the vicinity of CNS injury, providing a
scar-forming, reactive astrocytes after CNS injury in novel means of investigating the role of these cells in
adult animals.adult mice. As described previously, 7 days of s.c. GCV
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Astrocytes Regulate Leukocyte Infiltration been identified, but factors that regulate leukocytic mi-
gration and localization in specific anatomic compart-into CNS Parenchyma
ments are poorly understood (Springer, 1994). Our find-In higher vertebrates, leukocytes gain little entry into
ings demonstrate that astrocytes play a role in regulatingnormal CNS parenchyma, and the CNS inflammatory
the trafficking of leukocytes into injured CNS paren-response to injury differs from that of other tissues
chyma. Dysfunction of this role represents a novel po-(Dowding and Scholes, 1993; Perry et al., 1993). After
tential pathogenic mechanism for inflammatory distur-injury, neuronal degeneration, or injection of proinflam-
bances in the CNS.matory molecules, blood±borne monocytes and lym-
phocytes gain delayed and limited access to CNS paren-
Astrocyte Ablation Causes Failure of BBB Repairchyma, while polymorphonuclear neutrophils and mast
and Vasogenic Edemacells are largely excluded, suggesting that the CNS mi-
The anatomical correlate of the BBB is thought to residecroenvironment contains intrinsic, but unknown, antiin-
in tight junctions between endothelial cells of cerebralflammatory mechanisms (Perry et al., 1993; Hirschberg
capillaries, which are of high electrical resistance andand Schwartz, 1995; Raivich et al., 1998; Carson and
present a barrier to charged molecules (Brightman andSutcliffe, 1999). Our findings demonstrate that in the
Reese, 1969; Rubbin and Staddon, 1999). CNS endothe-absence of astrocytes, leukocytes gain increased and
lia are not fundamentally different from those in periph-prolonged entry into CNS parenchyma. Although some
eral tissues and are induced to adopt BBB-like proper-of this increase may at short survival times simply repre-
ties by unidentified factors in CNS tissue (Stewart andsent a heightened response to the presence of dead
Wiley, 1981). Endothelial cells of cerebral capillaries areand dying cells (i.e., transgene-expressing astrocytes
enveloped by astrocyte foot processes, and severalkilled by GCV or neurons dying secondary to loss of
lines of evidence suggest that astrocytes are importantastrocytes), available evidence indicates that this is un-
in establishing the BBB: (1) grafts of astrocytes inducelikely to account for the level and duration of the re-
BBB-like properties in peripheral endothelia (Janzer andsponse. Others have reported that after induction of
Raff, 1987) and (2) coculture with astrocyte cell linesneuronal degeneration using different neurotoxins, the
induces tight junctions and increases the electrical re-inflammatory response is either composed largely of
sistance across endothelial and epithelial cell layers inactivated resident microglia or exhibits a modest num-
vitro (Hurst and Fritz, 1996; Veronesi, 1996). Astrocyteber of leukocytes that resolve entirely within days or
induction of the BBB has also been challenged by sev-several weeks (Streit and Kreutzberg, 1988; Andersson
eral experimental studies (Holash et al., 1993; Krum,et al., 1991; Riva-Depaty et al., 1994), indicating that the
1996). Our findings demonstrate an essential role for
presence of dead cells on its own is not sufficient to
astrocytes in BBB repair and are compatible with a
trigger pronounced leukocyte infiltration. In addition, at-
model requiring either direct contact between astrocyte
tenuation of neuronal degeneration in our GCV-treated
endfeet and blood vessel walls, or the local diffusion of
transgenic mice did not prevent infiltration of leukocytes an astrocyte-produced factor(s), for induction of BBB
into astrocyte ablated tissue. Thus, it can be argued properties in CNS endothelial cells.
that the absence of astrocytes contributed directly to Vasogenic brain edema can accompany disruption of
both the persisting and polymorphic nature of the in- the BBB with poor outcome in various clinical settings
creased leukocyte infiltration, particularly after the de- and has been neuropathologically associated with the
bris had been cleared at the longer survival times. pronounced swelling of reactive astrocytes (Klatzo,
It is not yet clear whether the increased leukocyte 1967). It has not been known if the astroglial changes
entry after astrocyte ablation is a consequence of BBB contribute to development of the edema, and if so,
disruption or of other factors. Available evidence sug- whether edema is actively triggered by reactive astro-
gests that the tight junctional complexes that form the cytes or results from a failure of astrocyte functions.
BBB by restricting the passage of macromolecules are Our findings support the latter possibility and suggest
not the sole mechanism regulating leukocyte trafficking that astrocyte failure could in this manner exacerbate a
in the CNS (Carson and Sutcliffe, 1999). Mechanisms by number of CNS disorders.
which astrocytes could dynamically modulate the entry
of leukocytes into normal or injured CNS parenchyma Reactive Astrocytes Protect Neurons
in addition to, and perhaps independently of, their influ- Astrocytes, and related astroglia in other neural sys-
ence on the tight junctional complexes of the BBB in- tems, provide nutritive, neurotrophic, and other support-
clude their ability to produce (1) both pro- and antiin- ive functions for neurons (Banker, 1980; Buchanan and
flammatory cytokines (Eddleston and Mucke, 1993; Benzer, 1993; Tsacppoulos and Magistretti, 1996; Bush
Ransohoff and Tani, 1998) and (2) extracellularly depos- et al., 1998). Our findings demonstrate the essential na-
ited molecules that positively and negatively influence ture of astrocyte functions for neuronal survival in the
the migration of many cell types and nerve fibers (Blake- injured adult CNS. There are several ways in which abla-
more and Crang, 1989; Grumet et al., 1993; Davies et tion of reactive astrocytes could have led rapidly to
al., 1997). In this context, it is noteworthy that ablation neuronal death in our mice. Injury is associated with
of GFAP-expressing enteric astroglia in our transgenic increased levels of extracellular glutamate (Faden et al.,
mice was also associated with pronounced infiltration 1989), and ablation of genes encoding astrocyte-gluta-
of small intestine mucosa by polymorphic leukocytes mate transporters is associated with increased seizuri-
(Bush et al., 1998). Trafficking signals that attract leuko- genesis and excitotoxicity (Rothstein et al., 1996). The
ability of simultaneously administered NMDA-receptorcytes to sites of injury and promote extravasation have
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control animals were derived from the same inbred line and hadantagonist to prevent some but not all neuronal death
similar genetic backgrounds. Genotyping by Southern blot or PCRafter ablation of astrocytes suggests that glutamate ex-
was confirmed postmortem by immunohistochemical demonstra-citotoxicity contributed to the neurodegeneration we
tion of HSV-TK. All mice used in experiments were at least 4 months
observed. Nevertheless, the partial nature of the protec- old. Mice were housed in a 12 hr light/dark cycle with controlled
tion suggests that in addition to loss of glutamate up- temperature and humidity and allowed free access to food and
water.take, other degenerative mechanisms may also have
contributed, such as loss of astrocyte-derived growth
Surgeryfactors, loss of nutritive and metabolic support, and/or
Surgery was performed under general anaesthesia using a combina-increased numbers and prolonged presence of inflam-
tion of i.p. injection of 0.3 mg/kg fentanyl and inhalation of halothane
matory cells. Our findings support and extend other in oxygen enriched air. Forebrain stab injuries through cerebral neo-
recent evidence that astrocyte loss or dysfunction repre- cortex, subcortical white matter, hippocampus, and thalamus were
made with a sterile number 11 scalpel blade held in rodent stereo-sents a potentially significant cause of neuronal degen-
taxic apparatus (David Kopf, Tujunga, CA). Beginning at the leveleration (Budd and Lipton, 1998; Lin et al., 1998).
of Bregma, a 3 to 4 mm longitudinal cut was made parallel to, and
1.5 mm lateral of, the midline, to a depth of 3.5 mm. GCV (Roche,
Reactive Astrocytes Restrict the Local Regrowth Welwyn Garden, United Kingdom) was administered continuously
of Nerve Fibers at a rate of 100 mg/kg/day (Bush et al., 1998) in sterile physiological
The effects of astrocytes on nerve fiber growth varies saline for 7 days via subcutaneously implanted osmotic minipumps
(Alzet, Palo Alto, CA). After a loading dose of 20 mg/kg i.p. prior towith their state of differentiation (Hatten et al., 1991).
forebrain stab injury, memantine (Tocris, Bristol, United Kingdom)Although CNS astrocytes support neurite outgrowth
was administered continuously at a rate of 2 mg/kg/day (Toggas etduring development and under certain conditions in
al., 1996) in sterile saline for 14 days via subcutaneously implanted
adults (Gage et al., 1988; Kawaja and Gage, 1991), evi- osmotic minipumps (Alzet). HRP (Type VI, Sigma [Dorset, United
dence accumulated for over a century suggests that Kingdom] 50 mg in 0.5 ml sterile 0.9% saline) was infused intrave-
after CNS injury, reactive astrocytes are a major obstacle nously 45 min before transcardial perfusion with mixed aldehydes
(Broadwell and Brightman, 1976). Astrocyte-enriched tissue culturesto the regeneration of damaged axons (Ramon y Cajal,
were prepared from brains of neonatal, nontransgenic mice of line1928; Reier et al., 1983). This suggestion is supported
7.1 (Bush et al., 1998); after 28 days of expansion and differentiationby observations such as: (1) reactive astrocytes at sites
in vitro, cell suspensions were prepared and grafted into GCV-
of the PNS±CNS transition zone surround and appear treated transgenic mice at 7 or 14 days after forebrain stab injury.
to prevent the entry of regenerating peripheral nerves Grafts consisted of 1 to 2 ml columns of cells (400,000 cells/ml)
into CNS (Liuzzi and Lasek, 1987); (2) both three-dimen- placed into two or three sites along the stab injury. Experiments
were conducted in accordance with the United Kingdom Animalsional cultures of mature astrocytes and astrocyte scar
Scientific Procedures Act, 1986.tissue maintained in vitro are nonpermissive to axon
growth (Fawcett et al., 1989; Rudge and Silver, 1990);
BRDU Treatment
and (3) extracellular matrix molecules produced by reac- Dividing reactive astroglia were labeled on day 3 postinjury by six
tive astrocytes are associated with failure of axon subcutaneous injections of 10 mg/kg BRDU (Sigma, St. Louis, MO)
growth (Davies et al., 1997). Our findings extend these dissolved in saline plus 0.007 N NaOH every 2 hr. Mice were perfused
11 days later and tissue processed for immunohistochemistry asobservations by demonstrating that genetic targeting
described below with the following modification: sections were pre-can be used to ablate reactive, scar-forming astrocytes
treated with 2M HCl for 30 min and then neutralized with three rinseswithin a time frame after injury that could have clinical
of PBS before addition of primary antibody.
relevance and provide direct evidence that scar-forming
astrocytes limit the growth of nerve fibers after CNS Histology
injury in vivo. Our findings support the view that removal Under terminal barbiturate anesthesia, mice were perfused trans-
cardially with buffered 4% paraformaldehyde for routine immunohis-of these cells, or neutralization of the molecules respon-
tochemistry, or with either 1.25% or 2.5% glutaraldehyde plus 2%sible for this effect, will be a required component of
paraformaldehyde for detection of HRP, or for electron microscopy.achieving substantial axon regeneration after injury in
Brains were removed, postfixed for a further 1±3 hr, and cryopro-
the mature mammalian CNS. Failure of axon regenera- tected in buffered 25% sucrose overnight. Frozen sections (40 mm)
tion and the exclusion of leukocytes from adult CNS were prepared on a sledge microtome. Immunohistochemistry was
performed using biotinylated secondary antibodies (DAKO, Cam-parenchyma are both features of higher, as compared
bridge, United Kingdom), biotin-avidin-peroxidase complex (Vec-with lower, vertebrates (Dowding and Scholes, 1993;
tor), and diaminobenzidine (DAB, Sigma) or Vector SG (Vector asLarner et al., 1995). Our combined findings enable us to
developing agents). Primary antibodies were: rabbit anti-HSV-TK
speculate that inhibition of nerve fiber growth by scar- (1:25,000; P. Collins), rabbit anti-GFAP (1:25,000; DAKO), rabbit anti-
forming reactive astrocytes may be an indirect biproduct rat IgG at (1:10,000; DAKO), sheep anti-BRDU (1:1000, Maine Bio-
of the evolution of trafficking cues that regulate leuko- technology Services, Portland, ME), rat anti-mouse CD-45 (1:1000;
Pharmingen, Oxford, United Kingdom), rabbit anti-fibronectincyte migration in CNS parenchyma, rather than the result
(1:4000; DAKO), and rabbit anti-neurofilament M (1:10,000; Chemi-of a primary evolutionary pressure against a detrimental
con, Harrow, United Kingdom). HRP was visualized directly by incu-consequence of maintaining a CNS environment that is
bation of sections in DAB (Broadwell and Brightman, 1976). Tomato±
permissive of axon regeneration. lectin (Sigma) binding was visualized with DAB (Acarin et al., 1996).
Tissue for electronmicroscopy was treated with osmium tetroxide
Experimental Procedures and embedded in Epon, and semithin sections were prepared at 1
mm and stained with Toluidine blue or ultrathin sections prepared
Animals at 50 nm and stained with uranyl acetate and lead citrate.
Transgenic mice used in this study were generated as described
(Bush et al., 1998), and all experimental as well as control animals Morphometry
used were obtained by mating heterozygous females with non- Cell counts were performed using an unbiased sampling procedure
(Gundersen et al., 1988). For counts of immunoreactive astrocytes,transgenic males of line 7.1. Thus, transgenic and nontransgenic
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areas of specimens were traced, and 30 3 14,273 mm2 counting of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpes vi-
rus in vitro and its mode of action against herpes simplex virus typeframes per mm2 were selected at random by a computer-driven
1. Proc. Natl. Acad. Sci. USA 80, 2767±2770.microscope stage (Computer Assisted Stereological Toolbox; Olym-
pus, Glostrup, Denmark). For counts of immunoreactive leukocytes, Choi, D.W. (1997). Background genes: out of sight, but not out of
areas extending 400 mm away from, and 800 mm along, the wound brain. Trends Neurosci. 20, 499±500.
margin on one side were traced, and 12 3 10276 mm2 counting Davies, S.J.A., Fitch, M.T., Memberg, S.P., Hall, A.K., Raisman, G.,
frames per mm2 were selected by the computer. The number of and Silver, J. (1997). Regeneration of adult axons in white matter
positive cells per counting frame was determined, and final counts tracts of the central nervous system. Nature 390, 680±683.
were expressed as number per mm2. Statistical evaluations were
Delaney, C.L., Brenner, M., and Messing, A. (1996). Conditional abla-performed by ANOVA with post hoc, independent, pairwise analysis.
tion of cerebellar astrocytes in postnatal transgenic mice. J. Neu-
rosci. 16, 6908±6918.
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